HEADER TRANSFERASE 14-NOV-19 6TFZ TITLE CRYSTAL STRUCTURE OF EGFR T790M/V948R IN COMPLEX WITH COVALENT TITLE 2 PYRROLOPYRIMIDINE 19 COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTO-ONCOGENE C-ERBB-1,RECEPTOR TYROSINE-PROTEIN KINASE COMPND 5 ERBB-1; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EGFR, ERBB, ERBB1, HER1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS HER2, EGFR, COVALENT INHIBITORS, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.NIGGENABER,M.P.MUELLER,D.RAUH REVDAT 4 24-JAN-24 6TFZ 1 REMARK REVDAT 3 04-NOV-20 6TFZ 1 JRNL REVDAT 2 07-OCT-20 6TFZ 1 JRNL REVDAT 1 30-SEP-20 6TFZ 0 JRNL AUTH J.LATEGAHN,J.HARDICK,T.GRABE,J.NIGGENABER,K.JEYAKUMAR, JRNL AUTH 2 M.KEUL,H.L.TUMBRINK,C.BECKER,L.HODSON,T.KIRSCHNER, JRNL AUTH 3 P.KLOVEKORN,J.KETZER,M.BAUMANN,S.TERHEYDEN,A.UNGER, JRNL AUTH 4 J.WEISNER,M.P.MULLER,W.A.L.VAN OTTERLO,S.BAUER,D.RAUH JRNL TITL TARGETING HER2-INSYVMA WITH COVALENT INHIBITORS-A FOCUSED JRNL TITL 2 COMPOUND SCREENING AND STRUCTURE-BASED DESIGN APPROACH. JRNL REF J.MED.CHEM. V. 63 11725 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32931277 JRNL DOI 10.1021/ACS.JMEDCHEM.0C00870 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.10 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 53043 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2652 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.1000 - 4.8013 1.00 2861 151 0.1851 0.2043 REMARK 3 2 4.8013 - 3.8116 1.00 2748 145 0.1440 0.1604 REMARK 3 3 3.8116 - 3.3299 1.00 2709 142 0.1664 0.2182 REMARK 3 4 3.3299 - 3.0255 1.00 2696 142 0.1761 0.2032 REMARK 3 5 3.0255 - 2.8087 1.00 2675 141 0.1849 0.1909 REMARK 3 6 2.8087 - 2.6431 0.99 2660 140 0.1824 0.1958 REMARK 3 7 2.6431 - 2.5108 1.00 2659 140 0.1806 0.2346 REMARK 3 8 2.5108 - 2.4015 0.99 2643 139 0.1794 0.2285 REMARK 3 9 2.4015 - 2.3090 0.99 2645 139 0.1732 0.2204 REMARK 3 10 2.3090 - 2.2294 0.99 2641 140 0.1743 0.2275 REMARK 3 11 2.2294 - 2.1597 0.98 2611 137 0.1733 0.1976 REMARK 3 12 2.1597 - 2.0979 0.99 2649 139 0.1671 0.2116 REMARK 3 13 2.0979 - 2.0427 0.99 2589 137 0.1705 0.1877 REMARK 3 14 2.0427 - 1.9929 0.99 2629 138 0.1805 0.2588 REMARK 3 15 1.9929 - 1.9476 0.99 2598 137 0.1781 0.2660 REMARK 3 16 1.9476 - 1.9061 0.98 2607 136 0.1958 0.2284 REMARK 3 17 1.9061 - 1.8680 0.98 2589 136 0.2071 0.2853 REMARK 3 18 1.8680 - 1.8327 0.98 2603 137 0.2337 0.2763 REMARK 3 19 1.8327 - 1.8000 0.98 2579 136 0.2517 0.2949 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -6.5784 5.3908 10.1417 REMARK 3 T TENSOR REMARK 3 T11: 0.2145 T22: 0.1510 REMARK 3 T33: 0.1527 T12: 0.0146 REMARK 3 T13: 0.0053 T23: 0.0048 REMARK 3 L TENSOR REMARK 3 L11: 1.6456 L22: 0.3384 REMARK 3 L33: 0.7434 L12: 0.0766 REMARK 3 L13: 0.2715 L23: -0.0915 REMARK 3 S TENSOR REMARK 3 S11: -0.0382 S12: -0.0119 S13: -0.0672 REMARK 3 S21: -0.0114 S22: 0.0140 S23: 0.0030 REMARK 3 S31: 0.0031 S32: -0.1268 S33: 0.0246 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6TFZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1292104065. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-SEP-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9150 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53054 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 45.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 13.29 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.2500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 14.02 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.510 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5J9Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30 % PEG3350, 100 MM MGSO4, 4 % REMARK 280 ETHYLEN GLYCOLE 7.5 MG/ML EGFR T790M/V948R (IN 100 MM NACL, 25 REMARK 280 MM TRIS-HCL, 10 % GLYCEROL, 1 MM TCEP, PH 8.0) 1 UL RESERVOIR + REMARK 280 1 UL PROTEIN SOLUTION), VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 38.25000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.10000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.25000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.10000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.25000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.25000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 690 REMARK 465 SER A 691 REMARK 465 HIS A 692 REMARK 465 MET A 693 REMARK 465 ALA A 694 REMARK 465 SER A 695 REMARK 465 GLY A 696 REMARK 465 GLU A 697 REMARK 465 ALA A 698 REMARK 465 PRO A 699 REMARK 465 ASN A 700 REMARK 465 PRO A 753 REMARK 465 LYS A 754 REMARK 465 ALA A 859 REMARK 465 LYS A 860 REMARK 465 LEU A 861 REMARK 465 LEU A 862 REMARK 465 GLY A 863 REMARK 465 ALA A 864 REMARK 465 GLU A 865 REMARK 465 GLU A 866 REMARK 465 LYS A 867 REMARK 465 GLU A 868 REMARK 465 TYR A 869 REMARK 465 HIS A 870 REMARK 465 ALA A 871 REMARK 465 GLU A 872 REMARK 465 GLY A 873 REMARK 465 GLY A 874 REMARK 465 GLY A 983 REMARK 465 ASP A 984 REMARK 465 GLU A 985 REMARK 465 ARG A 986 REMARK 465 MET A 987 REMARK 465 HIS A 988 REMARK 465 LEU A 989 REMARK 465 PRO A 990 REMARK 465 SER A 991 REMARK 465 PRO A 992 REMARK 465 THR A 993 REMARK 465 ASP A 994 REMARK 465 SER A 995 REMARK 465 ASN A 996 REMARK 465 PHE A 997 REMARK 465 TYR A 998 REMARK 465 ARG A 999 REMARK 465 ALA A 1000 REMARK 465 LEU A 1001 REMARK 465 MET A 1002 REMARK 465 ASP A 1003 REMARK 465 GLU A 1004 REMARK 465 GLU A 1005 REMARK 465 ASP A 1006 REMARK 465 MET A 1007 REMARK 465 ASP A 1008 REMARK 465 ASP A 1009 REMARK 465 VAL A 1010 REMARK 465 VAL A 1011 REMARK 465 ASP A 1012 REMARK 465 ALA A 1013 REMARK 465 ASP A 1014 REMARK 465 GLU A 1015 REMARK 465 TYR A 1016 REMARK 465 LEU A 1017 REMARK 465 ILE A 1018 REMARK 465 PRO A 1019 REMARK 465 GLN A 1020 REMARK 465 GLN A 1021 REMARK 465 GLY A 1022 REMARK 465 GLY B 690 REMARK 465 SER B 691 REMARK 465 HIS B 692 REMARK 465 MET B 693 REMARK 465 ALA B 694 REMARK 465 SER B 695 REMARK 465 GLY B 696 REMARK 465 GLU B 697 REMARK 465 ALA B 698 REMARK 465 PRO B 699 REMARK 465 LEU B 862 REMARK 465 GLY B 863 REMARK 465 ALA B 864 REMARK 465 GLU B 865 REMARK 465 GLU B 866 REMARK 465 LYS B 867 REMARK 465 GLU B 868 REMARK 465 TYR B 869 REMARK 465 HIS B 870 REMARK 465 ALA B 871 REMARK 465 GLU B 872 REMARK 465 GLY B 873 REMARK 465 GLY B 874 REMARK 465 LYS B 875 REMARK 465 GLU B 985 REMARK 465 ARG B 986 REMARK 465 MET B 987 REMARK 465 HIS B 988 REMARK 465 LEU B 989 REMARK 465 PRO B 990 REMARK 465 SER B 991 REMARK 465 PRO B 992 REMARK 465 THR B 993 REMARK 465 ASP B 994 REMARK 465 SER B 995 REMARK 465 ASN B 996 REMARK 465 PHE B 997 REMARK 465 TYR B 998 REMARK 465 ARG B 999 REMARK 465 ALA B 1000 REMARK 465 LEU B 1001 REMARK 465 MET B 1002 REMARK 465 ASP B 1003 REMARK 465 GLU B 1004 REMARK 465 GLU B 1005 REMARK 465 ASP B 1006 REMARK 465 MET B 1007 REMARK 465 ASP B 1008 REMARK 465 ASP B 1009 REMARK 465 VAL B 1010 REMARK 465 VAL B 1011 REMARK 465 ASP B 1012 REMARK 465 ALA B 1013 REMARK 465 ASP B 1014 REMARK 465 GLU B 1015 REMARK 465 TYR B 1016 REMARK 465 LEU B 1017 REMARK 465 ILE B 1018 REMARK 465 PRO B 1019 REMARK 465 GLN B 1020 REMARK 465 GLN B 1021 REMARK 465 GLY B 1022 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 701 CG CD OE1 NE2 REMARK 470 LEU A 703 CG CD1 CD2 REMARK 470 LYS A 716 CG CD CE NZ REMARK 470 LYS A 737 CG CD CE NZ REMARK 470 ASN A 756 CG OD1 ND2 REMARK 470 LYS A 757 CG CD CE NZ REMARK 470 GLU A 758 CG CD OE1 OE2 REMARK 470 GLU A 762 CG CD OE1 OE2 REMARK 470 TYR A 764 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 875 CG CD CE NZ REMARK 470 ARG A 962 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 982 CG CD OE1 NE2 REMARK 470 GLN B 701 CG CD OE1 NE2 REMARK 470 LYS B 713 CG CD CE NZ REMARK 470 LYS B 737 CG CD CE NZ REMARK 470 LYS B 739 CG CD CE NZ REMARK 470 GLU B 749 CG CD OE1 OE2 REMARK 470 SER B 752 OG REMARK 470 LYS B 754 CG CD CE NZ REMARK 470 ASN B 756 CG OD1 ND2 REMARK 470 LYS B 757 CG CD CE NZ REMARK 470 GLU B 758 CG CD OE1 OE2 REMARK 470 GLU B 762 CG CD OE1 OE2 REMARK 470 LYS B 806 CG CD CE NZ REMARK 470 ASN B 808 CG OD1 ND2 REMARK 470 LEU B 858 CG CD1 CD2 REMARK 470 LYS B 860 CG CD CE NZ REMARK 470 LEU B 861 CG CD1 CD2 REMARK 470 VAL B 876 CG1 CG2 REMARK 470 GLN B 894 CG CD OE1 NE2 REMARK 470 GLU B 922 CG CD OE1 OE2 REMARK 470 ARG B 962 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 982 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 770 O HOH A 1201 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 783 -138.79 -132.72 REMARK 500 ARG A 836 -10.13 76.67 REMARK 500 ASP A 837 46.24 -146.58 REMARK 500 THR B 783 -129.69 -125.05 REMARK 500 ARG B 836 -14.25 83.58 REMARK 500 ASP B 837 50.80 -142.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N7B A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 1105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide N7B B 1101 and CYS B REMARK 800 797 DBREF 6TFZ A 695 1022 UNP P00533 EGFR_HUMAN 695 1022 DBREF 6TFZ B 695 1022 UNP P00533 EGFR_HUMAN 695 1022 SEQADV 6TFZ GLY A 690 UNP P00533 EXPRESSION TAG SEQADV 6TFZ SER A 691 UNP P00533 EXPRESSION TAG SEQADV 6TFZ HIS A 692 UNP P00533 EXPRESSION TAG SEQADV 6TFZ MET A 693 UNP P00533 EXPRESSION TAG SEQADV 6TFZ ALA A 694 UNP P00533 EXPRESSION TAG SEQADV 6TFZ MET A 790 UNP P00533 THR 790 ENGINEERED MUTATION SEQADV 6TFZ ARG A 948 UNP P00533 VAL 948 ENGINEERED MUTATION SEQADV 6TFZ GLY B 690 UNP P00533 EXPRESSION TAG SEQADV 6TFZ SER B 691 UNP P00533 EXPRESSION TAG SEQADV 6TFZ HIS B 692 UNP P00533 EXPRESSION TAG SEQADV 6TFZ MET B 693 UNP P00533 EXPRESSION TAG SEQADV 6TFZ ALA B 694 UNP P00533 EXPRESSION TAG SEQADV 6TFZ MET B 790 UNP P00533 THR 790 ENGINEERED MUTATION SEQADV 6TFZ ARG B 948 UNP P00533 VAL 948 ENGINEERED MUTATION SEQRES 1 A 333 GLY SER HIS MET ALA SER GLY GLU ALA PRO ASN GLN ALA SEQRES 2 A 333 LEU LEU ARG ILE LEU LYS GLU THR GLU PHE LYS LYS ILE SEQRES 3 A 333 LYS VAL LEU GLY SER GLY ALA PHE GLY THR VAL TYR LYS SEQRES 4 A 333 GLY LEU TRP ILE PRO GLU GLY GLU LYS VAL LYS ILE PRO SEQRES 5 A 333 VAL ALA ILE LYS GLU LEU ARG GLU ALA THR SER PRO LYS SEQRES 6 A 333 ALA ASN LYS GLU ILE LEU ASP GLU ALA TYR VAL MET ALA SEQRES 7 A 333 SER VAL ASP ASN PRO HIS VAL CYS ARG LEU LEU GLY ILE SEQRES 8 A 333 CYS LEU THR SER THR VAL GLN LEU ILE MET GLN LEU MET SEQRES 9 A 333 PRO PHE GLY CYS LEU LEU ASP TYR VAL ARG GLU HIS LYS SEQRES 10 A 333 ASP ASN ILE GLY SER GLN TYR LEU LEU ASN TRP CYS VAL SEQRES 11 A 333 GLN ILE ALA LYS GLY MET ASN TYR LEU GLU ASP ARG ARG SEQRES 12 A 333 LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL SEQRES 13 A 333 LYS THR PRO GLN HIS VAL LYS ILE THR ASP PHE GLY LEU SEQRES 14 A 333 ALA LYS LEU LEU GLY ALA GLU GLU LYS GLU TYR HIS ALA SEQRES 15 A 333 GLU GLY GLY LYS VAL PRO ILE LYS TRP MET ALA LEU GLU SEQRES 16 A 333 SER ILE LEU HIS ARG ILE TYR THR HIS GLN SER ASP VAL SEQRES 17 A 333 TRP SER TYR GLY VAL THR VAL TRP GLU LEU MET THR PHE SEQRES 18 A 333 GLY SER LYS PRO TYR ASP GLY ILE PRO ALA SER GLU ILE SEQRES 19 A 333 SER SER ILE LEU GLU LYS GLY GLU ARG LEU PRO GLN PRO SEQRES 20 A 333 PRO ILE CYS THR ILE ASP VAL TYR MET ILE MET ARG LYS SEQRES 21 A 333 CYS TRP MET ILE ASP ALA ASP SER ARG PRO LYS PHE ARG SEQRES 22 A 333 GLU LEU ILE ILE GLU PHE SER LYS MET ALA ARG ASP PRO SEQRES 23 A 333 GLN ARG TYR LEU VAL ILE GLN GLY ASP GLU ARG MET HIS SEQRES 24 A 333 LEU PRO SER PRO THR ASP SER ASN PHE TYR ARG ALA LEU SEQRES 25 A 333 MET ASP GLU GLU ASP MET ASP ASP VAL VAL ASP ALA ASP SEQRES 26 A 333 GLU TYR LEU ILE PRO GLN GLN GLY SEQRES 1 B 333 GLY SER HIS MET ALA SER GLY GLU ALA PRO ASN GLN ALA SEQRES 2 B 333 LEU LEU ARG ILE LEU LYS GLU THR GLU PHE LYS LYS ILE SEQRES 3 B 333 LYS VAL LEU GLY SER GLY ALA PHE GLY THR VAL TYR LYS SEQRES 4 B 333 GLY LEU TRP ILE PRO GLU GLY GLU LYS VAL LYS ILE PRO SEQRES 5 B 333 VAL ALA ILE LYS GLU LEU ARG GLU ALA THR SER PRO LYS SEQRES 6 B 333 ALA ASN LYS GLU ILE LEU ASP GLU ALA TYR VAL MET ALA SEQRES 7 B 333 SER VAL ASP ASN PRO HIS VAL CYS ARG LEU LEU GLY ILE SEQRES 8 B 333 CYS LEU THR SER THR VAL GLN LEU ILE MET GLN LEU MET SEQRES 9 B 333 PRO PHE GLY CYS LEU LEU ASP TYR VAL ARG GLU HIS LYS SEQRES 10 B 333 ASP ASN ILE GLY SER GLN TYR LEU LEU ASN TRP CYS VAL SEQRES 11 B 333 GLN ILE ALA LYS GLY MET ASN TYR LEU GLU ASP ARG ARG SEQRES 12 B 333 LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL SEQRES 13 B 333 LYS THR PRO GLN HIS VAL LYS ILE THR ASP PHE GLY LEU SEQRES 14 B 333 ALA LYS LEU LEU GLY ALA GLU GLU LYS GLU TYR HIS ALA SEQRES 15 B 333 GLU GLY GLY LYS VAL PRO ILE LYS TRP MET ALA LEU GLU SEQRES 16 B 333 SER ILE LEU HIS ARG ILE TYR THR HIS GLN SER ASP VAL SEQRES 17 B 333 TRP SER TYR GLY VAL THR VAL TRP GLU LEU MET THR PHE SEQRES 18 B 333 GLY SER LYS PRO TYR ASP GLY ILE PRO ALA SER GLU ILE SEQRES 19 B 333 SER SER ILE LEU GLU LYS GLY GLU ARG LEU PRO GLN PRO SEQRES 20 B 333 PRO ILE CYS THR ILE ASP VAL TYR MET ILE MET ARG LYS SEQRES 21 B 333 CYS TRP MET ILE ASP ALA ASP SER ARG PRO LYS PHE ARG SEQRES 22 B 333 GLU LEU ILE ILE GLU PHE SER LYS MET ALA ARG ASP PRO SEQRES 23 B 333 GLN ARG TYR LEU VAL ILE GLN GLY ASP GLU ARG MET HIS SEQRES 24 B 333 LEU PRO SER PRO THR ASP SER ASN PHE TYR ARG ALA LEU SEQRES 25 B 333 MET ASP GLU GLU ASP MET ASP ASP VAL VAL ASP ALA ASP SEQRES 26 B 333 GLU TYR LEU ILE PRO GLN GLN GLY HET N7B A1101 41 HET SO4 A1102 5 HET SO4 A1103 5 HET SO4 A1104 5 HET SO4 A1105 5 HET N7B B1101 57 HET SO4 B1102 5 HET SO4 B1103 5 HET SO4 B1104 5 HET EDO B1105 10 HETNAM N7B ~{N}-[2-(2-HYDROXYETHYLOXY)-5-[4-[[1-(PHENYLMETHYL) HETNAM 2 N7B INDAZOL-5-YL]AMINO]-7~{H}-PYRROLO[2,3-D]PYRIMIDIN-5- HETNAM 3 N7B YL]PHENYL]PROPANAMIDE HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 N7B 2(C31 H29 N7 O3) FORMUL 4 SO4 7(O4 S 2-) FORMUL 12 EDO C2 H6 O2 FORMUL 13 HOH *218(H2 O) HELIX 1 AA1 LYS A 708 THR A 710 5 3 HELIX 2 AA2 ASN A 756 VAL A 769 1 14 HELIX 3 AA3 CYS A 797 HIS A 805 1 9 HELIX 4 AA4 LYS A 806 ILE A 809 5 4 HELIX 5 AA5 GLY A 810 ARG A 831 1 22 HELIX 6 AA6 ALA A 839 ARG A 841 5 3 HELIX 7 AA7 PRO A 877 MET A 881 5 5 HELIX 8 AA8 ALA A 882 ARG A 889 1 8 HELIX 9 AA9 THR A 892 THR A 909 1 18 HELIX 10 AB1 PRO A 919 SER A 921 5 3 HELIX 11 AB2 GLU A 922 LYS A 929 1 8 HELIX 12 AB3 THR A 940 CYS A 950 1 11 HELIX 13 AB4 ASP A 954 ARG A 958 5 5 HELIX 14 AB5 LYS A 960 ARG A 973 1 14 HELIX 15 AB6 ASP A 974 LEU A 979 1 6 HELIX 16 AB7 ASN B 700 LEU B 704 5 5 HELIX 17 AB8 LYS B 708 THR B 710 5 3 HELIX 18 AB9 SER B 752 LYS B 754 5 3 HELIX 19 AC1 ALA B 755 SER B 768 1 14 HELIX 20 AC2 CYS B 797 HIS B 805 1 9 HELIX 21 AC3 LYS B 806 ILE B 809 5 4 HELIX 22 AC4 GLY B 810 ARG B 831 1 22 HELIX 23 AC5 ALA B 839 ARG B 841 5 3 HELIX 24 AC6 PHE B 856 LEU B 861 5 6 HELIX 25 AC7 PRO B 877 MET B 881 5 5 HELIX 26 AC8 ALA B 882 ARG B 889 1 8 HELIX 27 AC9 THR B 892 THR B 909 1 18 HELIX 28 AD1 PRO B 919 SER B 921 5 3 HELIX 29 AD2 GLU B 922 LYS B 929 1 8 HELIX 30 AD3 THR B 940 TRP B 951 1 12 HELIX 31 AD4 ASP B 954 ARG B 958 5 5 HELIX 32 AD5 LYS B 960 ARG B 973 1 14 HELIX 33 AD6 ASP B 974 LEU B 979 1 6 SHEET 1 AA1 6 ARG A 705 ILE A 706 0 SHEET 2 AA1 6 GLY A 779 LEU A 782 1 O ILE A 780 N ARG A 705 SHEET 3 AA1 6 VAL A 786 GLN A 791 -1 O ILE A 789 N GLY A 779 SHEET 4 AA1 6 ILE A 740 LEU A 747 -1 N LYS A 745 O LEU A 788 SHEET 5 AA1 6 GLY A 724 TRP A 731 -1 N THR A 725 O GLU A 746 SHEET 6 AA1 6 PHE A 712 GLY A 721 -1 N LEU A 718 O VAL A 726 SHEET 1 AA2 2 VAL A 843 THR A 847 0 SHEET 2 AA2 2 HIS A 850 ILE A 853 -1 O LYS A 852 N LEU A 844 SHEET 1 AA3 6 ARG B 705 ILE B 706 0 SHEET 2 AA3 6 GLY B 779 LEU B 782 1 O ILE B 780 N ARG B 705 SHEET 3 AA3 6 VAL B 786 GLN B 791 -1 O ILE B 789 N GLY B 779 SHEET 4 AA3 6 ILE B 740 LEU B 747 -1 N ALA B 743 O MET B 790 SHEET 5 AA3 6 GLY B 724 TRP B 731 -1 N TRP B 731 O ILE B 740 SHEET 6 AA3 6 PHE B 712 SER B 720 -1 N GLY B 719 O VAL B 726 SHEET 1 AA4 2 VAL B 843 THR B 847 0 SHEET 2 AA4 2 HIS B 850 ILE B 853 -1 O LYS B 852 N LEU B 844 LINK SG CYS A 797 CAM N7B A1101 1555 1555 1.88 LINK SG CYS B 797 CAM N7B B1101 1555 1555 1.80 SITE 1 AC1 23 LEU A 718 GLY A 719 SER A 720 VAL A 726 SITE 2 AC1 23 ALA A 743 LYS A 745 MET A 766 CYS A 775 SITE 3 AC1 23 LEU A 788 MET A 790 GLN A 791 MET A 793 SITE 4 AC1 23 CYS A 797 ASP A 800 ARG A 841 LEU A 844 SITE 5 AC1 23 THR A 854 ASP A 855 LEU A 858 HOH A1208 SITE 6 AC1 23 HOH A1252 HOH A1292 HOH A1294 SITE 1 AC2 10 LYS A 846 HIS A 850 LYS A 852 HOH A1209 SITE 2 AC2 10 HOH A1219 HOH A1258 LYS B 846 HIS B 850 SITE 3 AC2 10 LYS B 852 HOH B1259 SITE 1 AC3 7 LYS A 846 THR A 847 HIS A 850 HOH A1219 SITE 2 AC3 7 ARG B 776 GLN B 791 HOH B1238 SITE 1 AC4 5 GLY A 810 SER A 811 GLN A 976 HOH A1221 SITE 2 AC4 5 HOH A1234 SITE 1 AC5 6 ASP A 800 HOH A1208 ILE B 715 LYS B 716 SITE 2 AC5 6 VAL B 717 TYR B 727 SITE 1 AC6 7 ARG A 776 GLN A 791 HOH A1248 LYS B 846 SITE 2 AC6 7 THR B 847 HIS B 850 HOH B1206 SITE 1 AC7 7 GLY B 721 ALA B 722 PHE B 723 GLY B 724 SITE 2 AC7 7 LYS B 745 ARG B 841 ASP B 855 SITE 1 AC8 3 ARG B 803 LYS B 913 HOH B1202 SITE 1 AC9 4 HIS A 773 GLN A 849 HIS A 850 ASP B 770 SITE 1 AD1 25 GLY B 719 SER B 720 VAL B 726 ALA B 743 SITE 2 AD1 25 LYS B 745 MET B 766 CYS B 775 MET B 790 SITE 3 AD1 25 GLN B 791 MET B 793 GLY B 796 LEU B 798 SITE 4 AD1 25 LEU B 799 ASP B 800 TYR B 801 ARG B 841 SITE 5 AD1 25 VAL B 843 LEU B 844 THR B 854 ASP B 855 SITE 6 AD1 25 PHE B 856 ALA B 859 HOH B1211 HOH B1268 SITE 7 AD1 25 HOH B1276 CRYST1 76.500 82.500 90.200 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013072 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012121 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011086 0.00000